T1	Participants 55 108	type 2 diabetic patients under good glycemic control.
T2	Participants 521 590	78 drug-naive type 2 diabetic patients whose HbA1c was less than 6.5%
T3	Participants 1361 1412	type 2 diabetic patients with good glycemic control
